uniQure (QURE) Cash from Operations (2016 - 2026)
uniQure (QURE) recorded quarterly Cash from Operations of 38243000.0 in Q1 2026, up 50.7% quarter-over-quarter from 77569000.0 in Q4 2025, and up 13.28% on a YoY basis from 33759359.05 in Q1 2025.
uniQure (QURE) Cash from Operations (2016 - 2026) Analysis & Trends
uniQure's Cash from Operations history runs 11 years deep, the most recent figure standing at 38243000.0 for Q1 2026.
- In Q1 2026, Cash from Operations rose 13.28% year-over-year to 38243000.0; the TTM figure through Mar 2026 stood at 172106000.0 (down 3.52% YoY), while the FY2025 annual figure was 177963000.0, up 2.61% from the prior year.
- Cash from Operations was 38243000.0 for Q1 2026 at uniQure, up from 77569000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 38911000.0 in Q3 2023 to a low of 78302000.0 in Q1 2023.
- Historically, Cash from Operations has averaged 40583705.88 across 5 years, with a median of 44100000.0 in 2025.
- Biggest YoY gain for Cash from Operations was 179.42% in 2023; the steepest drop was 263.55% in 2023.
- A 5-year view of Cash from Operations shows it stood at 54680000.0 in 2022, then rose by 9.4% to 49541000.0 in 2023, then fell by 6.67% to 52844000.0 in 2024, then slumped by 46.79% to 77569000.0 in 2025, then soared by 50.7% to 38243000.0 in 2026.
- The last three Cash from Operations figures came in at 38243000.0 (Q1 2026), 77569000.0 (Q4 2025), and 16399000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.49 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.43 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | uniQure | 2.88 Bn | 2.88 Bn | 3.34 Mn | -38.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -38.24 Mn |
| Mar 31, 2026 | -38.24 Mn |
| Dec 31, 2025 | -77.57 Mn |
| Dec 31, 2025 | -77.57 Mn |
| Sep 30, 2025 | -16.40 Mn |
| Sep 30, 2025 | -16.40 Mn |
| Jun 30, 2025 | -39.90 Mn |
| Jun 30, 2025 | -39.90 Mn |
| Mar 31, 2025 | -44.10 Mn |
| Mar 31, 2025 | -44.10 Mn |
| Dec 31, 2024 | -52.84 Mn |
| Dec 31, 2024 | -52.84 Mn |
| Sep 30, 2024 | -36.60 Mn |
| Sep 30, 2024 | -36.60 Mn |
| Jun 30, 2024 | -32.71 Mn |
| Jun 30, 2024 | -32.71 Mn |
| Mar 31, 2024 | -60.58 Mn |
| Mar 31, 2024 | -60.58 Mn |
| Dec 31, 2023 | -49.54 Mn |
| Dec 31, 2023 | -49.54 Mn |